This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Merck Patent Gmbh. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: The Innovations of Marcus Frohme
Introduction
Marcus Frohme is a notable inventor based in Edingen, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of polypeptides and polynucleotides. His work has implications for diagnostic assays, showcasing the potential of his inventions in medical applications.
Latest Patents
Marcus Frohme holds a patent for "Human extracellular signal regulated kinases - ERK-7 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques." This patent also includes methods for utilizing ERK-7 polypeptides and polynucleotides in diagnostic assays. His innovative approach has led to advancements in understanding and utilizing these biological components.
Career Highlights
Frohme is associated with Merck Patent GmbH, where he continues to develop and refine his inventions. His work at Merck has allowed him to collaborate with leading experts in the field, further enhancing the impact of his research.
Collaborations
Some of his notable coworkers include Simon Lawrence Goodman and Burkhard Scharm. Their collaborative efforts contribute to the innovative environment at Merck, fostering advancements in biotechnology.
Conclusion
Marcus Frohme's contributions to the field of biotechnology through his patents and collaborations highlight his role as a significant inventor. His work continues to influence diagnostic methods and the understanding of biological processes.